title: [Immunoglobulins in primary antibody deficiency: should they also be used in sepsis and other indications?].
abstract: Immunoglobulin is a blood product prepared from the plasma of healthy donors. The therapeutic use of polyvalent immunoglobulins is an established therapy in primary antibody deficiencies, in idiopathic thrombocytopenic purpura (ITP) and in Guillain-Barré syndrome. However, there is an ongoing debate about the efficacy of polyvalent immunoglobulins as adjunctive therapy for sepsis. The paper presented here critically discusses the modern studies investigating the use of immunoglobulins in different diseases. The main focus is the use of immunoglobulins in patients with sepsis or septic shock.
authors: Klinik für Intensivmedizin, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Deutschland.
authors: S
authors: S
authors: Kluge
authors: G
authors: G
authors: de Heer
authors: A
authors: A
authors: Nierhaus
authors: G
authors: G
authors: Kreymann
mesh_terms: D003422:Critical Care; D019317:Evidence-Based Medicine; D006801:Humans; D007116:Immunization, Passive; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy*; D018805:Sepsis / Q000188:drug therapy*; D016896:Treatment Outcome